JV
Publications
147
Views
59,503
Downloads
9,925
Supervised works
3
Items per page
1 - 147 of 147
Title Published in Access level OA Policy Year Views Downloads
Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation systemFrontiers in public health
accessLevelPublic
2025 90 17
Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in SwitzerlandKidney International Reports
accessLevelPublic
2025 25 9
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid TumorsCancer research communications
accessLevelPublic
2024 64 52
Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyBMC infectious diseases
accessLevelPublic
2024 21 11
Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ?Open forum infectious diseases
accessLevelPublic
2024 80 24
Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant RecipientsTransplant international
accessLevelPublic
2024 78 29
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort StudyAmerican journal of transplantation
accessLevelPublic
2024 17 16
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3)The journal of infectious diseases
accessLevelPublic
2024 438 369
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella speciesFrontiers in medicine
accessLevelPublic
2024 60 13
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter studyBone marrow transplantation
accessLevelPublic
2024 45 13
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivationBlood advances
accessLevelPublic
2024 56 33
Néphrologie solidaire : la coopération Genève-YaoundéRevue médicale suisse
accessLevelPublic
2023 55 34
Vaccine-preventable infections among solid organ transplant recipients in SwitzerlandJAMA network open
accessLevelPublic
2023 91 23
Donor-derived fulminant herpes simplex virus hepatitis after liver transplantation : Two cases and review of literatureTransplant infectious disease
accessLevelPublic
2023 102 51
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort StudyFrontiers in immunology
accessLevelPublic
2023 84 15
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantationLeukemia & lymphoma
accessLevelPublic
2023 48 19
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trialClinical infectious diseases
accessLevelPublic
2023 71 25
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocolDiagnostic and prognostic research
accessLevelPublic
2023 32 25
An automated histological classification system for precision diagnostics of kidney allograftsNature medicine
accessLevelRestricted
2023 43 0
Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical TrialClinical infectious diseases
accessLevelPublic
2023 110 59
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 45 26
Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological UpdateOpen forum infectious diseases
accessLevelPublic
2023 89 38
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantationFrontiers in immunology
accessLevelPublic
2023 48 24
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 77 30
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 eraHLA
accessLevelPublic
2023 20 13
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort studyFrontiers in immunology
accessLevelPublic
2022 137 46
Personalized immunotherapy with encapsulated cell technology : Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumorsESMO Congress 2022
accessLevelPublic
2022 54 35
Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHDBlood
accessLevelPublic
2022 393 70
Regulation of HLA class I expression by non-coding gene variationsPLOS genetics
accessLevelPublic
2022 123 56
A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort StudyTransplant international
accessLevelPublic
2022 139 64
Atopy as an independent predictor for long-term patient and graft survival after kidney transplantationFrontiers in rheumatology & clinical immunology
accessLevelPublic
2022 126 21
Use of statins after liver transplantation is associated with improved survival: results of a nationwide studyAlimentary pharmacology & therapeutics
accessLevelPublic
2022 100 61
Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatmentsClinical transplantation
accessLevelPublic
2022 99 197
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 180 61
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 151 77
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationBlood advances
accessLevelPublic
2021 264 85
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort studyPLOS ONE
accessLevelPublic
2021 254 266
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018Antimicrobial resistance and infection control
accessLevelPublic
2021 318 74
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 285 1
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationLeukemia
accessLevelPublic
2020 356 246
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationNPJ Vaccines
accessLevelPublic
2020 437 104
CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune ResponseFrontiers in Immunology
accessLevelPublic
2020 199 139
Immunologic clearance of a BK virus-associated metastatic renal allograft carcinomaTransplantation
accessLevelPublic
2020 297 244
Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsyPediatric Transplantation
accessLevelRestricted
2020 363 2
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantationBlood
accessLevelRestricted
2020 312 0
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationJournal of Clinical Oncology
accessLevelRestricted
2020 154 0
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort StudyClinical Infectious Diseases
accessLevelPublic
2020 269 112
Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCTHuman Immunology
accessLevelRestricted
2020 160 13
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort studyThe Lancet. Haematology
accessLevelRestricted
2020 214 0
Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipientsTransplantation
accessLevelPublic
2020 324 157
Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic NeuronsStem Cells and Development
accessLevelPrivate
2020 285 0
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseRheumatology
accessLevelRestricted
2020 280 8
Vitamin d status and risk of infections after liver transplantation in the swiss transplant cohort studyTransplant International
accessLevelRestricted
2019 478 0
Management of allergy transfer upon solid organ transplantationAmerican Journal of Transplantation
accessLevelPublic
2019 349 231
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationBone Marrow Transplantation
accessLevelPublic
2019 405 97
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort StudyTransplant Infectious Disease
accessLevelRestricted
2018 489 0
Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejectionJournal of Clinical Investigation
accessLevelPublic
2018 421 168
Identification of seven novel HLA class I and II allelesHLA
accessLevelRestricted
2018 216 0
Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective studyBMC Nephrology
accessLevelPublic
2018 519 181
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactionsJournal of Clinical Investigation
accessLevelPublic
2018 440 177
Factors associated with immune hemolytic anemia after pediatric liver transplantationPediatric Transplantation
accessLevelRestricted
2018 336 1
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineThe Pharmacogenomics Journal
accessLevelPublic
2018 602 211
A Systematic Review and Meta-Analysis of HCV ClearanceLiver international
accessLevelRestricted
2017 526 1
The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protectionMolecular Ecology
accessLevelPublic
2017 564 307
Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02HLA
accessLevelRestricted
2017 520 0
Immunogenicity of anti-HLA antibodies in pancreas and islet transplantationCell transplantation
accessLevelRestricted
2016 514 3
Human Cytomegalovirus Infection Enhances NK Cell Activity In VitroTransplantation direct
accessLevelPublic
2016 597 452
A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantationLiver international
accessLevelRestricted
2016 517 1
Identification of the novel HLA-B*07:261 alleleHLA
accessLevelRestricted
2016 496 0
Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies?Modern rheumatology
accessLevelRestricted
2015 652 0
Kidney paired donation: a plea for a Swiss National ProgrammeSchweizerische medizinische Wochenschrift
accessLevelPublic
2015 678 237
Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial PresentationTransplantation direct
accessLevelRestricted
2015 482 2
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximabAnnals of hematology
accessLevelRestricted
2015 565 2
Long-term follow-up of cadaveric breast augmentation: what can we learn?Aesthetic surgery journal
accessLevelRestricted
2015 590 2
Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic MalignanciesBone marrow research
accessLevelPublic
2015 545 94
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B HaplotypesTransplantation
accessLevelRestricted
2015 488 0
Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapyJournal of immunology research
accessLevelRestricted
2014 487 0
Prédispositions génétiques dans l'allergie médicamenteuse : importance du HLARevue médicale suisse
accessLevelRestricted
2014 478 0
KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipientsGenes and immunity
accessLevelRestricted
2014 613 0
Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantationTransplant immunology
accessLevelRestricted
2014 665 2
Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cellsMethods in molecular biology
accessLevelRestricted
2013 619 1
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in childrenPloS one
accessLevelPublic
2013 666 362
Transplanted human pancreatic islets after long-term insulin independenceAmerican journal of transplantation
accessLevelRestricted
2013 800 1
The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson's diseaseStem cell research & therapy
accessLevelPublic
2013 938 287
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomyLeukemia
accessLevelPublic
2012 1,222 528
HLA and non-HLA polymorphisms in renal transplantationSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 628 1
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantationPediatric transplantation
accessLevelRestricted
2012 696 0
Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitationsStem cells and development
accessLevelPublic
2012 649 722
Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoringCell transplantation
accessLevelRestricted
2012 566 0
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
accessLevelRestricted
2012 677 0
Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?Tissue antigens
accessLevelRestricted
2012 666 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 989 571
Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipientsClinical journal of the American Society of Nephrology
accessLevelRestricted
2011 588 0
Introduction: Immunopathology and the promise of stem cell researchSeminars in immunopathology
accessLevelPublic
2011 622 134
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 836 8
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantationAmerican journal of transplantation
accessLevelRestricted
2011 689 0
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activityCell transplantation
accessLevelRestricted
2011 662 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
accessLevelRestricted
2011 624 0
How to cross immunogenetic hurdles to human embryonic stem cell transplantationSeminars in immunopathology
accessLevelPublic
2011 592 265
The role of natural killer cells in human solid organ and tissue transplantationJournal of innate immunity
accessLevelRestricted
2011 531 0
Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantationTransplantation
accessLevelRestricted
2010 620 0
Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppressionTransplantation
accessLevelRestricted
2010 624 0
Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipientsClinical immunology
accessLevelRestricted
2010 611 0
The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylationThe Journal of immunology
accessLevelRestricted
2009 657 0
Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cellsJournal of Cellular and Molecular Medicine
accessLevelPublic
2009 566 101
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipientsTransplant international
accessLevelRestricted
2009 600 0
Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year markAmerican journal of transplantation
accessLevelRestricted
2009 920 6
Sequence of a novel HLA-A2 allele in a haematopoietic stem cell donor of the international registryTissue antigens
accessLevelRestricted
2009 596 0
Pluripotent stem cells as new drugs? The example of Parkinson's diseaseInternational journal of pharmaceutics
accessLevelRestricted
2009 714 3
A new HLA-DR4 allele, DRB1*0474, with an unusual residue at position 77Tissue antigens
accessLevelRestricted
2008 602 1
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantationTransplantation
accessLevelRestricted
2008 849 0
Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantationAmerican journal of transplantation
accessLevelRestricted
2008 735 0
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytesInternational immunology
accessLevelRestricted
2008 545 164
DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 allelesTissue antigens
accessLevelRestricted
2008 547 0
Human herpesvirus-6 variant A encephalomyelitisNeurology
accessLevelRestricted
2008 630 0
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptorsArthritis Research and Therapy
accessLevelPublic
2007 200 109
Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximabTransplant international
accessLevelRestricted
2007 790 0
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineExperimental Hematology
accessLevelRestricted
2007 163 0
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistanceAntimicrobial Agents and Chemotherapy
accessLevelRestricted
2007 205 0
Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cellsJournal of Immunological Methods
accessLevelRestricted
2007 163 0
Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complicationsBlood
accessLevelRestricted
2006 588 0
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantationSchweizerische medizinische Wochenschrift
accessLevelPublic
2006 495 274
Acute humoral rejection in kidney allograft following a third-party arterial transplantationAmerican journal of transplantation
accessLevelRestricted
2006 607 0
Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating typeJournal of Clinical Microbiology
accessLevelRestricted
2005 171 0
Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivityLiver transplantation
accessLevelPublic
2005 498 423
Pseudovasculitis and corticosteroid therapyClinical rheumatology
accessLevelPublic
2005 542 212
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniaeAntimicrobial Agents and Chemotherapy
accessLevelPublic
2005 155 82
Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection markerYeast
accessLevelRestricted
2004 134 0
Cellular and Gene Therapy for Major Histocompatibility Complex Class II DeficiencyNews in physiological sciences
accessLevelRestricted
2004 71 0
A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid originImmunogenetics
accessLevelRestricted
2004 221 0
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytesEuropean Journal of Immunology
accessLevelPublic
2004 214 164
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptorsBlood
accessLevelPublic
2003 222 167
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporterAntimicrobial Agents and Chemotherapy
accessLevelPublic
2003 154 63
Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiencyMolecular therapy
accessLevelRestricted
2002 589 0
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assaysTransplant Immunology
accessLevelRestricted
2002 127 0
Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAPMolecular and cellular biology
accessLevelRestricted
2001 495 0
A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YMolecular and cellular biology
accessLevelRestricted
2000 615 0
Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoterJournal of Molecular Biology
accessLevelRestricted
2000 603 0
Molecular genetics of the Bare lymphocyte syndromeReviews in immunogenetics
2000 538 0
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expressionImmunological reviews
accessLevelRestricted
2000 627 0
CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complexGenes & development
accessLevelRestricted
2000 445 0
The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expressionMicrobes and infection
accessLevelRestricted
1999 503 0
CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexesInternational immunology
accessLevelRestricted
1999 575 0
Genetic and molecular definition of complementation group D in MHC class II deficiencyHuman molecular genetics
accessLevelRestricted
1998 579 0
MHC class II deficiency: definition of a new complementation groupImmunobiology
1997 587 0
Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiencyHuman mutation
accessLevelRestricted
1997 553 0
Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiencyThe New England journal of medicine
accessLevelRestricted
1997 604 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack